Literature DB >> 3820229

Hydroxamic acid inhibitors of 5-lipoxygenase.

J B Summers, H Mazdiyasni, J H Holms, J D Ratajczyk, R D Dyer, G W Carter.   

Abstract

The hydroxamic acid functionality can be incorporated in a variety of simple molecules to produce potent inhibitors of 5-lipoxygenase. As an example of this, the structure-activity relationships in a series of omega-phenylalkyl and omega-naphthylalkyl hydroxamic acids are presented. Among the features described are the influence of hydrophobicity, aryl substitution, and modifications of the hydroxamate group on enzyme inhibitory potency. To assist in the selection of more potent hydroxamic acid inhibitors, a simple hypothesis about the nature of enzyme-inhibitor binding was devised. In this hypothesis, the structures of compounds were matched to a proposed geometry of arachidonic acid when bound to the enzyme. Compounds that match best without extending into disfavored regions were predicted to be the best inhibitors. Three series of hydroxamates selected according to this approach are described. Within these series are some of the most potent inhibitors of 5-lipoxygenase reported to date.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3820229     DOI: 10.1021/jm00386a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Targeting metalloproteins by fragment-based lead discovery.

Authors:  Sherida Johnson; Elisa Barile; Biancamaria Farina; Angela Purves; Jun Wei; Li-Hsing Chen; Sergey Shiryaev; Ziming Zhang; Irina Rodionova; Arpita Agrawal; Seth M Cohen; Andrei Osterman; Alex Strongin; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2011-06-16       Impact factor: 2.817

2.  Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors.

Authors:  Mark W Irvine; Blaise M Costa; Daniel Dlaboga; Georgia R Culley; Richard Hulse; Caroline L Scholefield; Palmi Atlason; Guangyu Fang; Richard Eaves; Richard Morley; Maria B Mayo-Martin; Mascia Amici; Zuner A Bortolotto; Lucy Donaldson; Graham L Collingridge; Elek Molnár; Daniel T Monaghan; David E Jane
Journal:  J Med Chem       Date:  2011-12-14       Impact factor: 7.446

3.  Inhibition of potato lipoxygenase by linoleyl hydroxamic acid: kinetic and EPR spectral evidence for a two-step reaction.

Authors:  Igor A Butovich; C Channa Reddy
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

4.  Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction.

Authors:  D Riendeau; J P Falgueyret; J Guay; N Ueda; S Yamamoto
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

5.  Substrate binding and protein conformational dynamics measured by 2D-IR vibrational echo spectroscopy.

Authors:  Ilya J Finkelstein; Haruto Ishikawa; Seongheun Kim; Aaron M Massari; M D Fayer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

6.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

7.  Kinetics and mechanism of degradation of Zileuton, a potent 5-lipoxygenase inhibitor.

Authors:  F J Alvarez; R T Slade
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

8.  BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases.

Authors:  D G Tang; L Li; Z Zhu; B Joshi; C R Johnson; L J Marnett; K V Honn; J D Crissman; S Krajewski; J C Reed; J Timar; A T Porter
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 9.  Carboxylic acid (bio)isosteres in drug design.

Authors:  Carlo Ballatore; Donna M Huryn; Amos B Smith
Journal:  ChemMedChem       Date:  2013-01-29       Impact factor: 3.466

10.  An E/Z conformational behaviour study on the trypanocidal action of lipophilic spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acids.

Authors:  Alexandra Tsatsaroni; Grigoris Zoidis; Panagiotis Zoumpoulakis; Andrew Tsotinis; Martin C Taylor; John M Kelly; George Fytas
Journal:  Tetrahedron Lett       Date:  2013-06-19       Impact factor: 2.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.